Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3692]

New “smart” immune cells: a breakthrough for long-lasting tumour destruction

New “smart” immune cells: a breakthrough for long-lasting tumour destruction

Drug-delivering aptamers target leukaemia stem cells for one-two knockout punch

Drug-delivering aptamers target leukaemia stem cells for one-two knockout punch

Researchers develop test using machine learning to help predict immunotherapy response in lymphoma patients

Researchers develop test using machine learning to help predict immunotherapy response in lymphoma patients

Getting cancer to unmask itself

Getting cancer to unmask itself

Combination immunotherapy shrank a variety of metastatic gastrointestinal cancers

Combination immunotherapy shrank a variety of metastatic gastrointestinal cancers

Research discovers a way to slow or block recurrence of glioblastoma

Research discovers a way to slow or block recurrence of glioblastoma

Inhibition of PCSK9: a promising enhancer for anti-PD-1/PD-L1 immunotherapy

Inhibition of PCSK9: a promising enhancer for anti-PD-1/PD-L1 immunotherapy

PP2A regulates CD8+ T cell effector functions through AKT signaling pathway: implications for immunotherapy

PP2A regulates CD8+ T cell effector functions through AKT signaling pathway: implications for immunotherapy

A new CAR-T-cell therapy tricks cancer cells with a decoy to increase treatment efficiency in B-cell Acute Lymphoblastic Leukaemia

A new CAR-T-cell therapy tricks cancer cells with a decoy to increase treatment efficiency in B-cell Acute...

New tool to boost cancer immunotherapy effects

New tool to boost cancer immunotherapy effects

More from ecancer